2m 2m 2m 2m 2m 2m 2m
BIOXCEL THERPTC (BTAI)
NASDAQ
$0.81+$0.001 (+0.15%)
Price as of Aug 21, 2026 7:47 PM EDT- $25.2MMarket Cap
- -83.86%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
BIOXCEL THERPTC (BTAI)
$0.81+$0.001 (+0.15%)
BTAI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.80 | ||
Change | +$0.005 (+0.66%) | ||
Open | $0.81 | ||
High | $0.86 | ||
Low | $0.79 | ||
Previous Close | $0.80 | ||
Volume | 1,239,566 | ||
30-Day Average Volume | 794,054 | ||
1-Week Change | -32.45% | ||
1-Month Change | -10.45% | ||
1-Year Change | -83.86% | ||
3-Year Change | -98.73% | ||
5-Year Change | -99.79% | ||
Fundamentals | |||
Shares Outstanding | 31.3M | ||
Total Assets | $28.8M | ||
Market Cap | $25.2M | ||
Enterprise Value | $116.8M | ||
Period: QTR TTM FY | |||
Revenue | $182,000.00 | ||
Net Income | -$14.7M | ||
Free Cash Flow | -$6.1M | ||
EBIT | -$11.2M | ||
EBITDA | -$11.2M | ||
Net Working Capital | -$108.4M | ||
EPS | -$0.49 | ||
Enterprise Value/EBITDA | -10 | ||
Enterprise Value/Revenue | 642 | ||
P/B | -0 | ||
P/E | -2 | ||
PEG | -0 | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 16 | ||
Last Split Date | 02/10/2025 | ||
Earnings & Revenue